The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.

about

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.

Item

http://www.wikidata.org/entity/Q52613909

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.

@en

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.

@nl

type

Item

label

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.

@en

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.

@nl

prefLabel

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.

@en

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.

@nl

P1476

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.

@en

P2093

Akira Murasawa

http://www.w3.org/2001/XMLSchema#string

Asami Abe

http://www.w3.org/2001/XMLSchema#string

Chinatsu Takai

http://www.w3.org/2001/XMLSchema#string

Daisuke Kobayashi

http://www.w3.org/2001/XMLSchema#string

Eriko Hasegawa

http://www.w3.org/2001/XMLSchema#string

Hajime Ishikawa

http://www.w3.org/2001/XMLSchema#string

Hiroshi Otani

http://www.w3.org/2001/XMLSchema#string

Ichiei Narita

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Nakazono

http://www.w3.org/2001/XMLSchema#string

Satoshi Ito

http://www.w3.org/2001/XMLSchema#string

P2860

Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.

Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study

Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era.

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.

Three years of treatment with minodronate in patients with postmenopausal osteoporosis.

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study.

2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

Effectiveness of Bone Density Measurement for Predicting Osteoporotic Fractures in Clinical Practice

P31

scholarly article

P356

10.2169/INTERNALMEDICINE.9885-17

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29607978

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

P932

6120818

http://www.w3.org/2001/XMLSchema#string